The effect of oral evening primrose oil on menopausal hot flashes: A randomized clinical trial

Archives of Gynecology and Obstetrics

Volumn 288, Issue 5, 2013, Pages 1075-1079

  Farzaneh, Farah ^a   Fatehi, Setareh ^b   Sohrabi, Mohammad Reza ^c   Alizadeh, Kamyab ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Taleghani Hospital   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Evening primrose; Hot flashes; Menopause

Indexed keywords

NUTRI PRIMROSE; PARACETAMOL; PLACEBO; PRIMROSE OIL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG EFFICACY; FEMALE; HEADACHE; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; MORBIDITY; NAUSEA; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SEXUAL BEHAVIOR; SOCIAL BEHAVIOR; TREATMENT RESPONSE;

FEMALE; HOT FLASHES; HUMANS; INTERPERSONAL RELATIONS; MENOPAUSE; MIDDLE AGED; OENOTHERA BIENNIS; PHYTOTHERAPY; PLANT EXTRACTS; QUALITY OF LIFE; SEEDS; SEVERITY OF ILLNESS INDEX; SEXUALITY; SOCIAL PARTICIPATION;

EID: 84886089227     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-013-2852-6     Document Type: Article

References (29)

1. Gold EB, Block G, Crawford S, Lachance L, FitzGerald G, Miracle H, Sherman S (2004) Lifestyle and demographic factors in relation to vasomotor symptoms: baseline results from the study of women's health across the nation. Am J Epidemiol 159(12):1189-1199. doi: 10.1093/aje/kwh168
2. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 288(3):321-333
3. Cheema D, Coomarasamy A, El-Toukhy T (2007) Non-hormonal therapy of post-menopausal vasomotor symptoms: a structured evidence-based review. Arch Gynecol Obstet 276(5):463-469. doi: 10.1007/s00404-007-0390-9
4. Park MK, Satoh N, Kumashiro M (2008) Mental workload under time pressure can trigger frequent hot flashes in menopausal women. Ind Health 46(3):261-268. doi: JST.JSTAGE/indhealth/46.261
5. Thurston RC, Blumenthal JA, Babyak MA, Sherwood A (2006) Association between hot flashes, sleep complaints, and psychological functioning among healthy menopausal women. Int J Behav Med 13(2):163-172. doi: 10.1207/s15327558ijbm1302-8
6. Vestergaard P, Hermann AP, Stilgren L, Tofteng CL, Sorensen OH, Eiken P, Nielsen SP, Mosekilde L (2003) Effects of 5 years of hormonal replacement therapy on menopausal symptoms and blood pressure - a randomised controlled study. Maturitas 46(2):123-132 pii: S0378512203001816
7. Panidis D, Rousso D, Kourtis A, Giannoulis C, Mavromatidis G, Stergiopoulos K (2001) Hormone replacement therapy at the threshold of 21st century. Eur J Obstet Gynecol Reprod Biol 99(2):154-164 [pii: S0301211501004055]
8. Espeland MA, Rapp SR, Shumaker SA, Brunner R, Manson JE, Sherwin BB, Hsia J, Margolis KL, Hogan PE, Wallace R, Dailey M, Freeman R, Hays J (2004) Conjugated equine estrogens and global cognitive function in postmenopausal women: women's health initiative memory study. JAMA 291(24):2959-2968. doi: 10.1001/jama.291.24.2959
9. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin replacement study (HERS) research group. JAMA 280(7):605-613
10. Beral V (2003) Breast cancer and hormone - replacement therapy in the million women study. Lancet 362(9382):419-427 [pii: S0140673603140652]
11. National Institutes of Health (2005) National institutes of health state-of-the-science conference statement: management of menopause-related symptoms Ann Intern Med 142(12 Pt 1):1003-1013 [pii: 0000605-200506210-00117]
12. Rossmanith WG, Ruebberdt W (2009) What causes hot flushes? The neuroendocrine origin of vasomotor symptoms in the menopause. Gynecol Endocrinol 25(5):303-314. doi: 10.1080/09513590802632514
13. Carroll DG (2006) Nonhormonal therapies for hot flashes in menopause. Am Fam Physician 73(3):457-464
14. Chenoy R, Hussain S, Tayob Y, O'Brien PM, Moss MY, Morse PF (1994) Effect of oral gamolenic acid from evening primrose oil on menopausal flushing. BMJ 308(6927):501-503
15. Bassey EJ, Littlewood JJ, Rothwell MC, Pye DW (2000) Lack of effect of supplementation with essential fatty acids on bone mineral density in healthy pre and postmenopausal women: two randomized controlled trials of Efacal versus calcium alone. Br J Nutr 83(6):629-635 [pii: S0007114500000805]
16. Conquer JA, Roelfsema H, Zecevic J, Graham TE, Holub BJ (2002) Effect of exercise on FA profiles in n-3 FA-supplemented and nonsupplemented premenopausal women. Lipids 37(10):947-951
17. Cancelo Hidalgo MJ, Castelo Branco C (2011) Optimizing soy isoflavones effect in postmenopausal women: the impact of timing on climacteric symptoms. Gynecol Endocrinol 27(9):696-700. doi: 10.3109/09513590.2010.526665
18. Carpenter JS (2001) The hot flash related daily interference scale: a tool for assessing the impact of hot flashes on quality of life following breast cancer. J Pain Symptom Manage 22(6):979-989 [pii: S0885392401003530]
19. Ziaei S, Kazemnejad A, Zareai M (2007) The effect of vitamin E on hot flashes in menopausal women. Gynecol Obstet Invest 64(4):204-207. doi: 10.1159/000106491
20. Yakoot M, Salem A, Omar AM (2011) Effectiveness of a herbal formula in women with menopausal syndrome. Forsch Komplementmed 18(5):264-268. doi: 10.1159/000333430
21. Loprinzi CL, Barton DL, Qin R (2011) Nonestrogenic management of hot flashes. J Clin Oncol 29(29):3842-3846. doi: 10.1200/JCO.2011.37.5865
22. Loprinzi CL, Sloan J, Stearns V, Slack R, Iyengar M, Diekmann B, Kimmick G, Lovato J, Gordon P, Pandya K, Guttuso T Jr, Barton D, Novotny P (2009) Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis. J Clin Oncol 27(17):2831-2837. doi: 10.1200/JCO.2008.19.6253
23. Loprinzi CL, Qin R, Balcueva EP, Flynn KA, Rowland KM Jr, Graham DL, Erwin NK, Dakhil SR, Jurgens DJ, Burger KN (2010) Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes, N07C1. J Clin Oncol 28(4):641-647. doi: 10.1200/JCO.2009.24.5647
24. Aidelsburger P, Schauer S, Grabein K, Wasem J (2012) Alternative methods for the treatment of post-menopausal troubles. GMS Health Technol Assess 8: Doc03. doi: 10.3205/hta000101
25. Bordeleau L, Pritchard KI, Loprinzi CL, Ennis M, Jugovic O, Warr D, Haq R, Goodwin PJ (2010) Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors. J Clin Oncol 28(35):5147-5152. doi: 10.1200/JCO.2010.29.9230
26. Maclennan AH, Broadbent JL, Lester S, Moore V (2004) Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev (4): CD002978 doi: 10.1002/14651858.CD002978.pub2
27. Stein DJ, Baldwin DS, Dolberg OT, Despiegel N, Bandelow B (2006) Which factors predict placebo response in anxiety disorders and major depression? An analysis of placebo-controlled studies of escitalopram. J Clin Psychiatry 67(11):1741-1746
28. Papakostas YG, Daras MD (2001) Placebos, placebo effect, and the response to the healing situation: the evolution of a concept. Epilepsia 42(12):1614-1625
29. van Die MD, Teede HJ, Bone KM, Reece JE, Burger HG (2009) Predictors of placebo response in a randomized, controlled trial of phytotherapy in menopause. Menopause 16(4):792-796. doi: 10.1097/GME.0b013e318199d5e6